Axiom Investment Management LLC

Position in MRK — Merck & Co., Inc.

CIK 1513703 NEW YORK, NY

Position in MRK

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$824,580

-$43,546 QoQ

Shares Held

6,417

-11.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

#2,272

of 3,769 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Axiom Investment Management LLC holds $9,628,805 across 10 Drug Manufacturers - General names. MRK ranks #6 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	86,053	$2,072,142
2	LLY	ELI LILLY & Co	1,400	$1,679,191
3	BMY	Bristol Myers Squibb Co	23,292	$1,342,081
4	ABBV	AbbVie Inc.	4,806	$1,209,381
5	JNJ	Johnson & Johnson	3,978	$1,010,288
6	MRK	Merck & Co., Inc. This page	6,417	$824,580
7	GILD	Gilead Sciences, Inc.	6,343	$801,374
8	NVS	Novartis AG	3,326	$521,249

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$824,580	6,417	-11.1%	Shares	Sole	2026-07-31
2026-03-31	$868,126	7,217	+236.6%	Shares	Sole	2026-05-26
2022-12-31	$237,875	2,144	+367.1%	Shares	Sole	2023-02-14
2022-09-30	$39,527	459	-89.1%	Shares	Sole	2022-11-14
2022-03-31	$344,609	4,200	-42.4%	Shares	Sole	2022-05-13
2021-12-31	$558,547	7,288	-17.7%	Shares	Sole	2022-02-02
2021-09-30	$665,016	8,854	+94.1%	Shares	Sole	2021-10-18
2021-06-30	$354,704	4,561	-0.9%	Shares	Sole	2021-08-16
2021-03-31	$354,916	4,604	+274.3%	Shares	Sole	2021-05-20
2020-12-31	$100,605	1,230	-82.3%	Shares	Sole	2021-02-11
2020-09-30	$577,408	6,961	+6.9%	Shares	Sole	2021-03-16
2020-06-30	$503,489	6,511	+44.3%	Shares	Sole	2021-03-16
2020-03-31	$347,069	4,511	—	Shares	Sole	2021-03-16
No filing history on record for this holder in this stock.